| 000 | 00000nam 2200000za 4500 |
| 001 | 9.854452 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107155051 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 180328s2018 onc o f000 0 eng d |
|---|
| 022 | |z1925-0835 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH113-24/2018-6E-PDF|zH113-24/2018-6E |
|---|
| 245 | 00|aIpconazole |h[electronic resource]. |
|---|
| 260 | |aOttawa : |bPest Management Regulatory Agency, Health Canada, |c2018. |
|---|
| 300 | |a3 p. |
|---|
| 490 | 1 |aProposed maximum residue limit, |x1925-0843 ; |vPMRL2018-06 |
|---|
| 500 | |aIssued also in French under title: Ipconazole. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a“27 March 2018.” |
|---|
| 520 | |a"Under the authority of the Pest Control Products Act, Health Canada’s Pest ManagementRegulatory Agency (PMRA) has concluded that the registration of the new end-use product Rancona V 100 Pro FS Fungicide, containing technical grade ipconazole and carboxin; and the addition of new uses on various commodities to the product labels of Rancona V RS Fungicide, containing technical grade ipconazole and carboxin, and Rancona 3.8 FS Fungicide, containing technical grade ipconazole, are acceptable. The evaluation of these ipconazole applications indicated that the end-use products have value and the human health and environmental risks associated with the new uses are acceptable"--P. 1. |
|---|
| 530 | |aIssued also in print format. |
|---|
| 692 | 07|2gccst|aFungicides |
|---|
| 692 | 07|2gccst|aCertification |
|---|
| 692 | 07|2gccst|aToxicology |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 710 | 1 |aCanada. |bPest Management Regulatory Agency. |
|---|
| 775 | 08|tIpconazole |w(CaOODSP)9.854453 |
|---|
| 830 | #0|aProposed maximum residue limit,|x1925-0843 ; |vPMRL2018-06.|w(CaOODSP)9.505147 |
|---|
| 856 | 40|qPDF|s155 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/h113-24/H113-24-2018-6-eng.pdf |
|---|